Related Experiment Video
Updated: Dec 27, 2025

05:04
Author Spotlight: A Live Cell Imaging Technique to Study Calcium Signaling and Acrosome Exocytosis in Mouse Sperm
Published on: October 13, 2023
1.5K
Sperm Micromotors for Cargo Delivery through Flowing Blood
Haifeng Xu1,2, Mariana Medina-Sánchez1, Manfred F Maitz3
1Institute for Integrative Nanosciences, Leibniz IFW Dresden, Helmholtzstraße 20, 01069 Dresden, Germany.
ACS Nano
|February 26, 2020
Summary
Hybrid sperm micromotors overcome blood flow challenges for targeted drug delivery. These biohybrid devices utilize sperm propulsion for effective movement and cargo transport in the circulatory system.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Reproductive Biology
Background:
- Synthetic micromotors face limitations in biological fluids due to insufficient thrust force.
- The circulatory system's high flow and complex composition impede micromotor functionality.
- Overcoming these challenges is crucial for in vivo applications like targeted drug delivery.
Purpose of the Study:
- To develop a hybrid sperm micromotor capable of navigating and functioning within the circulatory system.
- To enable active propulsion against blood flow for micromanipulation and cargo delivery.
- To investigate the potential of these micromotors as anticoagulant agents.
Main Methods:
- Development of a biohybrid system combining natural sperm with synthetic microstructures.
- Utilizing sperm flagella for propulsion and synthetic components for magnetic guidance and cargo loading.
- Magnetization of single sperm micromotors to enable assembly into train-like carriers.
Main Results:
- The hybrid sperm micromotors demonstrated active swimming against both continuous and pulsatile blood flow.
- The system successfully performed heparin cargo delivery, a key anticoagulant.
- Magnetized micromotors assembled into larger structures for enhanced cargo transport capacity.
Conclusions:
- Hybrid sperm micromotors offer a viable solution for untethered micromanipulation in the bloodstream.
- This biohybrid approach overcomes previous limitations of synthetic micromotors in complex biological environments.
- These micromotors show promise as novel anticoagulant agents for treating circulatory diseases.

